The Part D Subsidy Cliff: A Retirement Nightmare Waiting to Happen The federal subsidies for Medicare's Part D prescription drug program will cease on December 31, leaving millions of retirees without a significant source of financial relief.
These temporary subsidies were always intended to phase out after 2027 as part of the Inflation Reduction Act, but their early demise is a symptom of a broader trend in healthcare policy.
The Trump administration's decision to scrap these subsidies reflects a shift towards market based solutions that prioritize cost cutting over patient care.